Acamprosate Completed Phase 4 Trials for Pathological Gambling Disorder Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00571103Acamprosate in the Treatment of Pathological Gambling